Latest Environmental Testing News

Nova Minerals has identified fresh high-grade gold anomalies at its RPM area within Alaska’s Estelle Project, setting the stage for a pivotal 2026 drilling campaign.

Nova Minerals has identified a significant new gold-copper anomaly spanning 1,500 by 800 metres at its West Wing prospect within the Estelle Project in Alaska, based on 2025 surface sampling results. This discovery hints at a potentially distinct deposit style and sets the stage for targeted drilling in 2026.

Reach Resources reports exceptional metallurgical test results from its Murchison South Gold Project, highlighting high gold recoveries and favourable processing characteristics that support toll milling potential.

Nova Minerals’ 2025 drilling at the Korbel Gold Deposit in Alaska reveals a near-surface higher-grade core, supporting a pilot starter pit and promising cost efficiencies through ore sorting.

Nova Minerals’ 2025 drilling at the RPM North deposit in Alaska confirms significant eastern extensions and broad near-surface gold zones, underpinning potential resource upgrades ahead of a key Pre-Feasibility Study.

Power Minerals and Summit Nanotech have confirmed the technical viability of the Incahuasi Lithium Project in Argentina, outlining a clear pathway to production of 5,000 tonnes per annum of high-purity lithium carbonate over 20 years.

ALS Limited reported a robust half-year performance with underlying revenue up 13.3% and net profit after tax rising 17.2%, driven by strong growth in both Commodities and Life Sciences divisions. The company also declared a higher interim dividend and advanced its global expansion strategy.

Trajan Group Holdings Limited reported a 7.4% increase in revenue to $166.5 million for FY25, marking a significant turnaround with a return to profit after tax attributable to owners of $2.2 million. The company also reduced net debt and improved EBITDA by 26.2%, driven by organic growth and strategic acquisitions.

Nova Minerals has launched a 15,000-meter drilling campaign at its Estelle Project targeting gold and antimony, while advancing a US Department of Defense grant application to fast-track its antimony development.

Universal Biosensors reports a $1.59 million improvement in operating cash outflows for Q2 2025, maintaining $2.55 million in cash as it advances commercialization across blood, wine, and water testing markets.

ALS Limited delivered a robust FY25 performance with 16% revenue growth to $3 billion and underlying EBIT rising 4.7% to $515 million, driven by strong organic growth and strategic acquisitions. The company is advancing its Nuvisan integration ahead of schedule and has unveiled a $230 million investment plan to expand key laboratories, positioning itself for sustained growth amid market uncertainties.

ALS Limited reported a robust FY25 with $3 billion revenue driven by Life Sciences growth and resilient Commodities, announcing a $350 million equity raise to fund strategic expansion.